On December 27, Gelonghui reported that Abterra^ Medical (301097.SZ) announced that, 1. The "Comprehensive R&D Center Construction Project" originally implemented by its subsidiary Ningbo Tairuisi Technology Co., Ltd. cannot be completed and used in the short term due to various reasons such as policy adjustments at the implementation site. To further improve the efficiency of fundraising and protect the interests of the listed company and shareholders, the company plans not to implement the "Comprehensive R&D Center Construction Project," and intends to allocate all remaining fundraising to the "Thailand Production Base Construction Project"; 2. The company plans to allocate all surplus raised funds to the "Thailand Production Base Construction Project."